FDA analysis of J&J COVID vaccine booster sets the stage for public hearing
Johnson & Johnson has asked the Food and Drug Administration to authorize a booster for people 18 and older six months after initial immunization, with an option to vaccinate after two months.
Read more on NPR
Random Posts
Lorem 1
Technology
Circle Gallery
‹
›
Shooting
Racing
News
Lorem 4
Home
»
News
»
NPR
» NPR News: FDA analysis of J&J COVID vaccine booster sets the stage for public hearing
About Unknown
WePress Theme is officially developed by Templatezy Team. We published High quality Blogger Templates with Awesome Design for blogspot lovers.The very first Blogger Templates Company where you will find Responsive Design Templates.
Subscribe to:
Post Comments (Atom)
No comments